CIK 0001438533 · Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 262383102
- Phone
- 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 19,122 shares at an average $8.70 ($166,435)
- 4 Open-market sale SENIOR VICE PRESIDENT, R&D sold 4,764 shares at an average $8.71 ($41,495)
- 4 Open-market sale SVP, CHIEF ACCOUNTING OFFICER sold 2,820 shares at $8.53 ($24,058)
- 4 Open-market sale SVP, GC & CORPORATE SECRETARY sold 4,764 shares at an average $8.71 ($41,495)
- 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 4,195 shares at $8.53 ($35,789)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 2,174 shares at $8.53 ($18,547)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 3,818 shares at $8.53 ($32,573)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 19 of 65 · 1,286 filings